New Blog - Patient Focused Medicines Development

Recent Stories

Acknowledging the value of patient input

·
When it comes to ascribing value to patient involvement in the development of innovative medicines and med-tech, different stakeholders may have different perspectives. That was the finding of an...
+ Read more
Sort by
Sort by

More Stories

·

Framework Development

From the beginning, PFMD worked to develop a systematic approach that ensures co-creation based on existing knowledge and balanced collaboration with all relevant stakeholders. This allows us to move...
·

Reduce the burden of legal agreements with WECAN and MPE

Collaboration between pharmaceutical companies and patient advocates typically requires both parties to sign contracts covering various topics. These written agreements can often be too long and complex, and can...
·

Putting a figure on patient engagement

As part of the Fair Market Value global effort, we launched a survey in mid-December 2018. This was open to all types of stakeholders, and the goal was to...
·

Synapse – your tool for patient engagement

Synapse has evolved in the last year, from mapping to connecting the patient engagement ecosystem. The platform has grown 18% in initiatives and 30% in organisations since 2017, further...
·

The wide-ranging impact of patient access

Patient engagement means opening the door to patients for meaningful dialogue and contributions. A recent op ed in In Vivo explored several ways in which patient access can truly...
·

Europe highlights patient role in innovative medicines

The EU Innovative Medicines Initiative (IMI) is encouraging patients and patient groups to play their part in developing therapies of the future. With a budget of €3.3 billion (2014-2020),...
X